Back to company

EPITHERAPEUTICS ApS: Financial statements 2012

CVR: 30523067

EPITHERAPEUTICS ApS (CVR 30523067) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -11,928,543 and a net result of DKK -26,646,160. Equity amounted to DKK -9,126,244.

Gross Profit
-11,928,543 kr.
Profit/Loss
-26,646,160 kr.
Equity
-9,126,244 kr.
Total Assets
17,296,461 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is EPITHERAPEUTICS ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2012

Henrijette Elsebeth Richter joins the board of EPITHERAPEUTICS ApSAug 22, 2012

As of August 22, 2012, Henrijette Elsebeth Richter has joined the board of directors of EPITHERAPEUTICS ApS.

Stephan Christgau leaves the board of EPITHERAPEUTICS ApSAug 22, 2012

As of August 22, 2012, Stephan Christgau has left the board of directors of EPITHERAPEUTICS ApS.

EPITHERAPEUTICS ApS appoints new auditorMay 22, 2012

As of May 22, 2012, EY Danmark A/S has been appointed auditor of EPITHERAPEUTICS ApS.

Auditor steps down at EPITHERAPEUTICS ApSMay 22, 2012

As of May 22, 2012, Pryds Statsautoriseret Revisionsfirma has stepped down as auditor of EPITHERAPEUTICS ApS.

Christian Ellebæk Elling joins the board of EPITHERAPEUTICS ApSMay 22, 2012

As of May 22, 2012, Christian Ellebæk Elling has joined the board of directors of EPITHERAPEUTICS ApS.

Mette Kirstine Agger leaves the board of EPITHERAPEUTICS ApSMay 22, 2012

As of May 22, 2012, Mette Kirstine Agger has left the board of directors of EPITHERAPEUTICS ApS.

About EPITHERAPEUTICS ApS

EPITHERAPEUTICS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2008 and dissolved in 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee. In 2021, the company reported a gross profit of DKK 72,058 and a net result of DKK -21,073,661 compared with DKK -3,028,693 the year before. Equity amounted to DKK 9,205,571.